These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32076885)

  • 1. Exploring the Potential of Hydrophilic Matrix Combined with Insoluble Film Coating: Preparation and Evaluation of Ambroxol Hydrochloride Extended Release Tablets.
    Hu M; Zhu Z; Wu Y; Meng Q; Luo J; Wang H
    AAPS PharmSciTech; 2020 Feb; 21(3):93. PubMed ID: 32076885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robustness of barrier membrane coated metoprolol tartrate matrix tablets: Drug release evaluation under physiologically relevant in vitro conditions.
    Klein S; Seeger N; Mehta R; Missaghi S; Grybos R; Rajabi-Siahboomi A
    Int J Pharm; 2018 May; 543(1-2):368-375. PubMed ID: 29630933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Evaluation of Compression Coating Gastro-Floating Tablet of Alfuzosin Hydrochloride for Zero-Order Controlled Release.
    Gong L; Sun Y; Yu M; Gao Y; Zou M; Cheng G
    AAPS PharmSciTech; 2018 Oct; 19(7):3277-3286. PubMed ID: 30215168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
    Wang MY; Yang YP; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of ethylcellulose coating to hydrophilic matrices: a strategy to modulate drug release profile and reduce drug release variability.
    Mehta RY; Missaghi S; Tiwari SB; Rajabi-Siahboomi AR
    AAPS PharmSciTech; 2014 Oct; 15(5):1049-59. PubMed ID: 24848757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and comparative evaluation of in vitro, in vivo properties of novel controlled release compositions of paroxetine hydrochloride hemihydrate as against Geomatrix™ platform technology.
    Khatavkar UN; Shimpi SL; Jayaram Kumar K; Deo KD
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1175-86. PubMed ID: 22607046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.
    Abd-Elbary A; Haider M; Sayed S
    Pharm Dev Technol; 2012; 17(5):562-73. PubMed ID: 21428699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and dissolution kinetics study of hydrophilic matrix tablets with tramadol hydrochloride and different co-processed dry binders.
    Komersová A; Lochař V; Myslíková K; Mužíková J; Bartoš M
    Eur J Pharm Sci; 2016 Dec; 95():36-45. PubMed ID: 27496049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release.
    Al-Hanbali OA; Hamed R; Arafat M; Bakkour Y; Al-Matubsi H; Mansour R; Al-Bataineh Y; Aldhoun M; Sarfraz M; Dardas AKY
    Pak J Pharm Sci; 2018 Jan; 31(1(Suppl.)):345-351. PubMed ID: 29386164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
    Turner S; Federici C; Hite M; Fassihi R
    Drug Dev Ind Pharm; 2004 Sep; 30(8):797-807. PubMed ID: 15521326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
    Hamed R; Al Baraghthi T; Sunoqrot S
    Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimization of a floating osmotic pump system of ambroxol hydrochloride using central composite design-response surface methodology and its pharmacokinetics in Beagle dogs].
    Zhao F; Ma YL; Jin XL; Wang J; Cao DY
    Yao Xue Xue Bao; 2011 Dec; 46(12):1507-14. PubMed ID: 22375427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged-release minitablets with carbamazepine - preliminary observations in vitro.
    Dzajkowska M; Hanna K; Anna M; Maja S; Dagmara D; Anna S; Malgorzata S
    J Pharm Pharmacol; 2017 Apr; 69(4):471-479. PubMed ID: 28000299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
    Wu B; Shun N; Wei X; Wu W
    Pharm Dev Technol; 2007; 12(2):203-10. PubMed ID: 17510892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
    Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
    AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
    Cheng X; Sun M; Gao Y; Cao F; Zhai G
    Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.